These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30623114)

  • 1. Hyperinsulinemic hypoglycemia subtype glucokinase V91L mutant induces necrosis in β-cells via ATP depletion.
    Lu B; Tonne JM; Munoz-Gomez M; Ikeda Y
    Biochem Biophys Rep; 2019 Mar; 17():108-113. PubMed ID: 30623114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-330-3p contributes to INS-1 cell dysfunction by targeting glucokinase in gestational diabetes mellitus.
    Xiao Y; Ding J; Shi Y; Lin L; Huang W; Shen D; Wang W
    J Obstet Gynaecol Res; 2020 Jun; 46(6):864-875. PubMed ID: 32202040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.
    Cuesta-Muñoz AL; Huopio H; Otonkoski T; Gomez-Zumaquero JM; Näntö-Salonen K; Rahier J; López-Enriquez S; García-Gimeno MA; Sanz P; Soriguer FC; Laakso M
    Diabetes; 2004 Aug; 53(8):2164-8. PubMed ID: 15277402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to chronic high glucose induces beta-cell apoptosis through decreased interaction of glucokinase with mitochondria: downregulation of glucokinase in pancreatic beta-cells.
    Kim WH; Lee JW; Suh YH; Hong SH; Choi JS; Lim JH; Song JH; Gao B; Jung MH
    Diabetes; 2005 Sep; 54(9):2602-11. PubMed ID: 16123348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual allosteric activation mechanisms in monomeric human glucokinase.
    Whittington AC; Larion M; Bowler JM; Ramsey KM; Brüschweiler R; Miller BG
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11553-8. PubMed ID: 26283387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy.
    Wabitsch M; Lahr G; Van de Bunt M; Marchant C; Lindner M; von Puttkamer J; Fenneberg A; Debatin KM; Klein R; Ellard S; Clark A; Gloyn AL
    Diabet Med; 2007 Dec; 24(12):1393-9. PubMed ID: 17976205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction: glucokinase downregulation lowers interaction of glucokinase with mitochondria, resulting in apoptosis of pancreatic beta-cells.
    Lee JW; Kim WH; Lim JH; Song EH; Song J; Choi KY; Jung MH
    Cell Signal; 2009 Jan; 21(1):69-78. PubMed ID: 18940247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of liraglutide on β-cell-specific glucokinase-deficient neonatal mice.
    Shirakawa J; Tanami R; Togashi Y; Tajima K; Orime K; Kubota N; Kadowaki T; Goshima Y; Terauchi Y
    Endocrinology; 2012 Jul; 153(7):3066-75. PubMed ID: 22569791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg).
    Gilis-Januszewska A; Bogusławska A; Kowalik A; Rzepka E; Soczówka K; Przybylik-Mazurek E; Głowa B; Hubalewska-Dydejczyk A
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of a glucokinase point mutant in the treatment of diabetes mellitus.
    Lu G; Teng X; Zheng Z; Zhang R; Peng L; Zheng F; Liu J; Huang H; Xiong H
    Gene Ther; 2016 Apr; 23(4):323-9. PubMed ID: 26752353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.
    Gloyn AL; Noordam K; Willemsen MA; Ellard S; Lam WW; Campbell IW; Midgley P; Shiota C; Buettger C; Magnuson MA; Matschinsky FM; Hattersley AT
    Diabetes; 2003 Sep; 52(9):2433-40. PubMed ID: 12941786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association with nitric oxide synthase on insulin secretory granules regulates glucokinase protein levels.
    Markwardt ML; Nkobena A; Ding SY; Rizzo MA
    Mol Endocrinol; 2012 Sep; 26(9):1617-29. PubMed ID: 22771492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of glucokinase monogenic diabetes in pregnancy: current perspectives.
    Rudland VL
    Diabetes Metab Syndr Obes; 2019; 12():1081-1089. PubMed ID: 31372018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
    Christesen HB; Tribble ND; Molven A; Siddiqui J; Sandal T; Brusgaard K; Ellard S; Njølstad PR; Alm J; Brock Jacobsen B; Hussain K; Gloyn AL
    Eur J Endocrinol; 2008 Jul; 159(1):27-34. PubMed ID: 18450771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
    Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
    Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, treatment and genetic analysis of a case of hypoglycemia caused by glucokinase gene mutation.
    Li LY; Liu SQ; Shi Y; Zhao CC; Zhou HW; Zheng XQ
    Yi Chuan; 2022 Sep; 44(9):810-818. PubMed ID: 36384957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
    García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
    Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes.
    Cockburn BN; Ostrega DM; Sturis J; Kubstrup C; Polonsky KS; Bell GI
    Diabetes; 1997 Sep; 46(9):1434-9. PubMed ID: 9287043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.